Record · corpus.blog/posts/01a0f131-d4a3-73f4-911c-c7fc03b644eb
Octopus moves forward
multiple-sclerosis-research.org · 27 September 2026 · 3 min read
A post on multiple-sclerosis-research.org, published 27 September 2026, has not been cited by any blog yet (corpus.blog, measured 8 October 2026).
A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.
0blogs citing
| Citing blogs | 0 |
|---|---|
| Links | 0 |
| Anchor phrases | 0 |
| External links | 7 |
| Words captured | 535 |
Cited by
No blog we hold has cited this post yet.
Links from this post
Link
Host
msaustralia.org.au
pmc.ncbi.nlm.nih.gov
pmc.ncbi.nlm.nih.gov
journals.sagepub.com
pubmed.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
Similar posts
Bezisterim – the Best Long COVID Drug Trial Yet? BioVie Aims for a Big, Phase III Trial
healthrising.org
27 Sept 2026
A global phase III, double-blind, randomized trial of BNT327/PM8002 plus chemotherapy (chemo) compared to atezolizumab plus chemo in patients (pts) with first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Strength of evidence supporting cancer drug approvals in China, 2017-2021.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
A multicenter, randomized, controlled, pivotal trial of microbubble-enhanced transcranial focused ultrasound for patients with NSCLC brain metastases (LIMITLESS).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
TRIPLE-SWITCH (SWOG/CCTG-PR26): A randomized phase III clinical trial for the addition of docetaxel to androgen receptor pathway inhibitors in patients with metastatic castration sensitive prostate cancer (mCSPC) and suboptimal PSA response (NCT06592924).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Adaptive organoid-based precision therapy study in pancreatic cancer (ADOPT): A phase II single-arm study to evaluate the efficacy of patient-derived organoid (PDO)-directed therapy in advanced pancreatic ductal adenocarcinoma (PDAC).
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs
30 Sept 2026
Something wrong here? Report a problem